HOME >> MEDICINE >> NEWS
AMPAKINE compounds a new potential treatment for respiratory depression

Drug-induced respiratory depression is a life-threatening condition caused by analgesic, hypnotic, and anesthesia medications. Although it is a leading cause of death from the overdose of some classes of abused drugs, respiratory depression also arises during normal, physician-supervised procedures such as surgical anesthesia, post-operative analgesia, and as a result of normal out-patient management of pain from cancer, accidents, or illnesses.

The majority of adverse events occurring with these drugs take place during the dose adjustment period, when two or more central nervous depressants are taken together, or when patients take prescribed drugs in ways not intended by their physician.

Although only 0.5%-1.2% of total adverse drug events caused by prescription medications are respiratory in nature, these serious side effects account for 25%-30% of drug-induced deaths. Opiates and barbiturates are the primary drugs classes responsible for these effects. Opiates include the standard pain-killing drugs morphine, fentanyl, and codeine, as well as related products vicodin, hydrocodone, and oxycontin. Barbituates comprise the sedative drugs amobarbital, aprobarbital, butabarbital, pentobarbital, and others. Sleeping disorders are another common predisposing factor for respiratory depression, in this case known as sleep apnea.

Currently, the only way to counter opiate-induced respiratory depression is to administer opiate receptor antagonists, drugs that block the effectiveness of opiate analgesia. While this approach may prevent a serious side effect or even death, it dramatically reduces the effectiveness of drugs administered for management of severe pain.

Researchers at the University of Alberta (Edmonton, AB) and Cortex Pharmaceuticals (Irvine, CA) believe that AMPAKINE drugs may provide protection from drug-induced respiratory depression, while simultaneously allowing the sedative or analgesic to continue working as it
'"/>

Contact: Mark Varney
mvarney@cortexpharm.com
949-231-0672
Cortex Pharmaceuticals
4-Jun-2007


Page: 1 2 3 4 5

Related medicine news :

1. New oxidation methods streamline synthesis of important compounds
2. Depression among retired NFL players: Rates mirror the general public, but pain compounds symptoms
3. U of M researchers discover compounds to shrink tumors
4. Diagnosis and treatment of osteoporosis falls shortnon adherence compounds issue
5. New compounds fight chronic symptoms of bowel disorders
6. New synthetic compounds appear to prevent brain cell death
7. Phenolic compounds may explain Mediterranean diet benefits
8. Vitamin D compounds show promise for prevention of prostate cancer
9. Hebrew University researcher develops compounds to control bacteria
10. DNA vaccine against multiple sclerosis appears safe, potentially beneficial
11. Electric fields have potential as a cancer treatment

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/23/2019)... (PRWEB) , ... May 23, 2019 , ... Mirror Mirror ... 100. This exciting landmark represents years of dedication to patient satisfaction and top-notch medical ... to provide a welcoming location where patients can come for exceptional skincare and innovative, ...
(Date:5/23/2019)... ... May 23, 2019 , ... Dr. Earl ... Beauty network. , The Haute Beauty Network, well known for their exclusivity, and ... and our newest addition to the Haute Living partnership. , Haute Beauty offers ...
(Date:5/23/2019)... ... 23, 2019 , ... Thermal Product Solutions, a global manufacturer ... to the Medical Industry. , These Gruenberg walk-in ovens have maximum temperature ratings ... 72” H. The Gruenberg truck-in ovens were constructed from a structural steel frame ...
(Date:5/23/2019)... ... 23, 2019 , ... Hoban Law Group is proud to be partnering with ... is essential to help educate the public about the most sweeping cannabis reform policy ... do so than Times Square,” said Hoban Law Group Founder & President Bob Hoban. ...
(Date:5/23/2019)... FRANKLIN, Tenn. (PRWEB) , ... May 23, 2019 ... ... treatment and behavioral health services, announces the opening of its seventeenth treatment center, ... residential treatment facility is Summit’s first in the Sunflower State. The facility is ...
Breaking Medicine News(10 mins):
(Date:5/23/2019)... ... May 23, 2019 , ... Educators at public K-12 ... Grant from California Casualty at http://www.calcasmusicartsgrant.com . The entry deadline is June 30, ... and hear over and over how their arts and performance programs could use more ...
(Date:5/22/2019)... ... , ... A leading global health expert urged new Western University of Health ... care successes and builds on them to make better lives for all the people ... at the University of Washington and Institute Director of the Institute for Health Metrics, ...
(Date:5/22/2019)... ... May 22, 2019 , ... Southern Illinois University Edwardsville’s Mark ... (SOP). Luer has served as interim dean since July 2018. The appointment is subject ... its outstanding record of accomplishment during Dr. Luer’s service as interim dean, and we ...
Breaking Medicine Technology:
Cached News: